Regencell Bioscience Announces 38-for-1 Stock Split
Ticker: RGC · Form: 6-K · Filed: Jun 2, 2025 · CIK: 1829667
| Field | Detail |
|---|---|
| Company | Regencell Bioscience Holdings LTD (RGC) |
| Form Type | 6-K |
| Filed Date | Jun 2, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: stock-split, corporate-action
TL;DR
Regencell is doing a 38-for-1 stock split, giving shareholders 37 extra shares per share owned.
AI Summary
Regencell Bioscience Holdings Limited announced on June 2, 2025, that its board of directors approved a 38-for-one forward stock split, effective for shareholders of record on June 12, 2025. This means each shareholder will receive 37 additional shares for every share they own.
Why It Matters
A stock split can make shares more accessible to a wider range of investors by lowering the per-share price, potentially increasing liquidity.
Risk Assessment
Risk Level: low — This filing is a routine corporate action (stock split) and does not involve significant financial or operational changes.
Key Numbers
- 38-for-one — Stock Split Ratio (Indicates the number of new shares issued for each existing share.)
- 37 — Additional Shares per Share (The number of bonus shares shareholders will receive for each share held.)
Key Players & Entities
- Regencell Bioscience Holdings Limited (company) — The company announcing the stock split.
- June 12, 2025 (date) — Record date for the stock split.
- 38-for-one (stock_split_ratio) — The ratio of the forward stock split.
FAQ
What is the purpose of the 38-for-one forward stock split?
The filing does not explicitly state the purpose, but stock splits are often done to increase share liquidity and make the stock more accessible to investors.
Who is eligible to receive the additional shares?
Shareholders of record at the close of business on June 12, 2025, will receive the additional shares.
When is the record date for the stock split?
The record date is June 12, 2025.
What is the ratio of the stock split?
The stock split is a 38-for-one forward stock split, meaning shareholders will receive 37 additional shares for every one share they hold.
What type of filing is this?
This is a Form 6-K, which is a report of foreign private issuers pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on June 2, 2025 regarding Regencell Bioscience Holdings Ltd (RGC).